The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)